Evidence map›Paper›PMID 29285387›Full record

ArticleMolecular and clinical oncology2017

Breast cancer cases of female patients under 35 years of age in Togo: A series of 158 cases.

Tchin Darré, Mazamaesso Tchaou, Koué Folligan, Abdoulatif Amadou, Bidamin N'Timon, Lantam Sonhaye, Abdoul-Samadou Aboubakari, Koffi Amégbor, Koffi Akpadza, Gado Napo Koura

Abstract read
In one paragraph

Article in Molecular and clinical oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Breast Cancer in Togolese Women: Imaging and Clinicopathological Findings.Breast cancer : basic and clinical research · 2021
    Article
  5. Article
  6. Article
  7. Male Breast Cancer in Togo: Imaging and Clinicopathological Findings.International journal of breast cancer · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tchin DarréDepartment of Pathology, The University Teaching Hospital of Lomé, Lomé BP1515, Togo.
Mazamaesso TchaouDepartment of Imaging, The University Teaching Hospital of Lomé, Lomé BP1515, Togo.
Koué FolliganDepartment of Histology-Embryology, The University Teaching Hospital of Lomé, Lomé BP1515, Togo.
Abdoulatif AmadouDepartment of Imaging, The University Teaching Hospital of Lomé, Lomé BP1515, Togo.
Bidamin N'TimonDepartment of Imaging, The University Teaching Hospital of Lomé, Lomé BP1515, Togo.
Lantam SonhayeDepartment of Imaging, The University Teaching Hospital of Lomé, Lomé BP1515, Togo.
Abdoul-Samadou AboubakariDepartment of Obstetrics and Gynecology, University Teaching Hospital of Lomé and Kara, Kara BP18, Togo.
Koffi AmégborDepartment of Pathology, The University Teaching Hospital of Lomé, Lomé BP1515, Togo.
Koffi AkpadzaDepartment of Obstetrics and Gynecology, University Teaching Hospital of Lomé and Kara, Kara BP18, Togo.
Gado Napo KouraDepartment of Pathology, The University Teaching Hospital of Lomé, Lomé BP1515, Togo.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer in young female patients represents a public health problem in developing countries. The objectives of the study were to study the epidemiological and histological characteristics of breast cancer in female patients under 35 years of age. This was a retrospective analytical study of a series of 158 cases of breast cancer in female patients under 35 years of age, conducted at the University Teaching Hospital of Lomé between 2000 and 2015. A total of 158 cases were collected, representing 36.2% (436) of all breast cancer cases. The average age of the patients was 30.9 years (range, 16-35 years). A family history of breast cancer at the 1st or 2nd degree was identified in 13.9% of cases. Genetic mutation studies were carried out for 7 patients, 5 of which revealed mutations (4 BRCA1 and 1 BRCA2). According to the locus, the cancer was located preferentially in the left breast in 88 cases (55.7%). Malignant mammary lesions were epithelial tumors (n=144 cases, 91.1%), infiltrating (n=125 cases, 79.1%) and non-infiltrating (n=19 cases, 12.0%). The other histological groups consisted of 8 cases of sarcomas (5 cases of angiosarcoma, 2 cases of fibrosarcoma and 1 case of Kaposi's sarcoma), 5 cases of lymphomas and one case of melanoma. Not otherwise specified infiltrating ductal carcinomas were SBR II and III in 43.2 and 35.2% of cases, respectively. The tumors classified as T4 were the most frequent (30.4%). Regarding the lymph node status, lymph node metastasis was noted in 22.8% of cases. Studies of hormone receptors were carried out in 23 patients and were positive for 11 patients: Estrogen receptor (ER)+plus progesterone receptor (PR)+(7 patients), ER+PR-(4 patients). Of the aforementioned 8 cases of sarcoma, 5 were angiosarcoma. The lymphomas were predominantly Burkitt's type for 4 cases. Mammary ultrasonography was performed in 45.6% of the patients and 54.4% underwent the combined ultrasonography and mammography. Ultrasound identified one or more sign of malignancy in 67 patients (42.4%), and combined ultrasonography and mammography classified 51.9% of lesions in BIRADS 4 and 5. The incidence of breast cancer in young Togolese patients is high. It is a disease distinguished by a delay in diagnosis, which contributes to the high number of cases that initially diagnosed at an advanced stage, particularly the high histo-prognosis grades of infiltrating ductal carcinoma. These results indicate a genetic origin; therefore, a thorough investigation into genetic mutations should be carried. In addition, further collaborative studies are required to verify these results.

Indexed as

Africacancer breastcancer registrycarcinomaimmunohistochemistryTogo

Identifiers

PMID29285387
PMCPMC5740822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.